MARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.735600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.350400E-01
Normal-vs-Stage2
3.208200E-01
Normal-vs-Stage3
3.294800E-01
Normal-vs-Stage4
9.317800E-01
Stage1-vs-Stage2
6.781600E-01
Stage1-vs-Stage3
3.650000E-02
Stage1-vs-Stage4
3.390000E-01
Stage2-vs-Stage3
1.98852999999666E-05
Stage2-vs-Stage4
1.799590E-01
Stage3-vs-Stage4
3.072500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.745200E-01
Normal-vs-AfricanAmerican
6.653600E-01
Normal-vs-Asian
4.332800E-01
Caucasian-vs-AfricanAmerican
6.067400E-01
Caucasian-vs-Asian
9.787000E-01
AfricanAmerican-vs-Asian
7.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.015200E-01
Normal-vs-Female
3.877600E-01
Male-vs-Female
6.085400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.912000E-01
Normal-vs-Age(41-60Yrs)
6.152000E-01
Normal-vs-Age(61-80Yrs)
3.319400E-01
Normal-vs-Age(81-100Yrs)
4.445800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.126400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.232800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.245000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.510400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.832800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.401400E-01
Normal-vs-Daily Drinker
4.502200E-01
Normal-vs-Weekly Drinker
8.440600E-01
Normal-vs-Occasional Drinker
6.011000E-01
Normal-vs-Social Drinker
6.485800E-01
Non Drinker-vs-Daily Drinker
3.207800E-01
Non Drinker-vs-Weekly Drinker
4.222200E-01
Non Drinker-vs-Occasional Drinker
5.577400E-01
Non Drinker-vs-Social Drinker
3.608400E-01
Daily Drinker-vs-Weekly Drinker
2.614400E-01
Daily Drinker-vs-Occasional Drinker
1.407360E-01
Daily Drinker-vs-Social Drinker
9.137500E-02
Weekly Drinker-vs-Occasional Drinker
5.445200E-01
Weekly Drinker-vs-Social Drinker
6.437600E-01
Occasional Drinker-vs-Social Drinker
6.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.283900E-02
Normal-vs-Grade 2
8.709900E-02
Normal-vs-Grade 3
1.827900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.104600E-01
Grade 1-vs-Grade 3
4.221600E-01
Grade 1-vs-Grade 4
8.283900E-02
Grade 2-vs-Grade 3
8.566800E-01
Grade 2-vs-Grade 4
8.709900E-02
Grade 3-vs-Grade 4
1.827900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.446200E-01
Normal-vs-NonDiabetic
2.740400E-01
Diabetic-vs-NonDiabetic
6.013200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.680800E-01
Normal-vs-NoPancreatitis
2.754000E-01
Pancreatitis-vs-NoPancreatitis
3.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.849600E-01
Normal-vs-N1
3.325200E-01
N0-vs-N1
5.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.283600E-01
Normal-vs-TP53-NonMutant
7.536200E-01
TP53-Mutant-vs-TP53-NonMutant
9.942000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
